ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,749Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 1206

$611K Total Retail Price of All Prescriptions

Rank: 84 out of 1206

393 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 8,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 435 408 1 1
AMLODIPINE BESYLATE 404 374 2 6
LEVOTHYROXINE SODIUM 264 232 3 2
OMEPRAZOLE 257 232 4 3
ATORVASTATIN CALCIUM 252 246 5 13
FUROSEMIDE 238 233 6 5
HYDROCODONE-ACETAMINOPHEN 232 209 S3 7 7
SERTRALINE HCL 218 177 8 22
LISINOPRIL 213 201 9 4
HYDROCHLOROTHIAZIDE 211 207 10 11
METOPROLOL SUCCINATE 211 200 10 15
POTASSIUM CHLORIDE 185 173 12 12
TRAZODONE HCL 175 146 13 37
LOSARTAN POTASSIUM 172 162 14 20
GLIMEPIRIDE 170 148 15 34
CELEBREX 146 142 16 84
ENALAPRIL MALEATE 137 135 17 45
WARFARIN SODIUM 131 111 18 8
NAMENDA 127 127 19 36
METFORMIN HCL ER 125 110 20 58
TERAZOSIN HCL 124 123 21 81
PREMARIN 123 104 R 22 147
LOVASTATIN 115 111 23 44
TRAMADOL HCL 110 91 24 17
ATENOLOL 101 101 25 14
METOPROLOL TARTRATE 100 99 26 9
PREDNISONE 97 81 27 28
ZETIA 97 88 27 73
FLUTICASONE PROPIONATE 80 68 29 42
CRESTOR 75 71 30 30
JANUVIA 73 73 31 87
LANSOPRAZOLE 67 50 32 128
GABAPENTIN 66 48 33 18
PANTOPRAZOLE SODIUM 65 58 34 54
HUMALOG 64 59 35 140
ESTRADIOL 63 56 R 36 203
TRIAMTERENE-HCTZ 62 62 37 33
LANTUS SOLOSTAR 61 55 38 85
CLONIDINE HCL 58 58 39 88
PROAIR HFA 57 53 40 49
NEXIUM 57 54 40 47
METFORMIN HCL 55 52 42 10
AZITHROMYCIN 54 51 43 46
ALLOPURINOL 54 52 43 24
DIOVAN 54 54 43 57
PEN NEEDLE 52 44 46 121
CYMBALTA 52 46 46 63
VERAPAMIL ER 51 51 48 97
ALENDRONATE SODIUM 51 51 48 19
QVAR 51 51 48 257
CITALOPRAM HBR 50 50 51 16
DILTIAZEM 24HR CD 50 50 51 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.